Diabetic cardiomyopathy: mechanisms, diagnosis and treatment.
about
Nitric oxide and peroxynitrite in health and diseaseGlycaemic, blood pressure and cholesterol control in 25 629 diabeticsCardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapiesPathophysiological Role of Peroxynitrite Induced DNA Damage in Human Diseases: A Special Focus on Poly(ADP-ribose) Polymerase (PARP)Forkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathyHigh glucose suppresses expression of equilibrative nucleoside transporter 1 (ENT1) in rat cardiac fibroblasts through a mechanism dependent on PKC-zeta and MAP kinasesEnhanced skeletal muscle expression of extracellular superoxide dismutase mitigates streptozotocin-induced diabetic cardiomyopathy by reducing oxidative stress and aberrant cell signaling.Diagnostic approaches for diabetic cardiomyopathy.Diastolic dysfunction in spontaneous type 2 diabetes rhesus monkeys: a study using echocardiography and magnetic resonance imaging.Novel therapeutic effects of sesamin on diabetes-induced cardiac dysfunction.Hyperglycemic and hyperlipidemic conditions alter cardiac cell biomechanical propertiesThe effect of Astragalus polysaccharides on attenuation of diabetic cardiomyopathy through inhibiting the extrinsic and intrinsic apoptotic pathways in high glucose -stimulated H9C2 cells.Targeting Peroxisome Proliferator-Activated Receptors Using Thiazolidinediones: Strategy for Design of Novel Antidiabetic DrugsHeart failure in the diabetic population - pathophysiology, diagnosis and management.3',4'-Dihydroxyflavonol antioxidant attenuates diastolic dysfunction and cardiac remodeling in streptozotocin-induced diabetic m(Ren2)27 ratsDiabetic cardiomyopathy, causes and effects.Chronic treatment with long acting phosphodiesterase-5 inhibitor tadalafil alters proteomic changes associated with cytoskeletal rearrangement and redox regulation in Type 2 diabetic hearts.Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategiesAlterations in connexin 43 during diabetic cardiomyopathy: competition of tyrosine nitration versus phosphorylation.Temporal dystrophic remodeling within the intrinsic cardiac nervous system of the streptozotocin-induced diabetic rat modelActivation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic miceInhibition of mitochondrial permeability transition pore restores the cardioprotection by postconditioning in diabetic hearts[Diabetic cardiomyopathy].Diabetic cardiomyopathy in Manipur.MicroRNAs involved in the mitogen-activated protein kinase cascades pathway during glucose-induced cardiomyocyte hypertrophy.Effect and mechanisms of zinc supplementation in protecting against diabetic cardiomyopathy in a rat model of type 2 diabetes.Altered oxido-reductive state in the diabetic heart: loss of cardioprotection due to protein disulfide isomeraseRole of oxidative stress in disease progression in Stage B, a pre-cursor of heart failure.Myocardial structure and function by echocardiography in relation to glucometabolic status in elderly subjects from 2 population-based cohorts: a cross-sectional study.Early myocardial dysfunction in streptozotocin-induced diabetic mice: a study using in vivo magnetic resonance imaging (MRI).Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice.The diabetic heart: too sweet for its own good?Effect of polysaccharide from Bacillus subtilis sp. on cardiovascular diseases and atherogenic indices in diabetic rats.Na+/Ca2+ exchanger-1 protects against systolic failure in the Akitains2 model of diabetic cardiomyopathy via a CXCR4/NF-κB pathway.Diacylglycerol kinase zeta inhibits myocardial atrophy and restores cardiac dysfunction in streptozotocin-induced diabetes mellitus.Restoration of defective L-type Ca2+ current in cardiac myocytes of type 2 diabetic db/db mice by Akt and PKC-ιHeart in diabetes: not only a macrovascular disease.Phospholipid-mediated signaling systems as novel targets for treatment of heart disease.Hybrid model for analysis of abnormalities in diabetic cardiomyopathy and diabetic retinopathy related imagesMethylglyoxal-Induced Endothelial Cell Loss and Inflammation Contribute to the Development of Diabetic Cardiomyopathy
P2860
Q24645400-26AAB8DE-AF75-4AC2-8CDC-F8823BABAAA9Q26781082-A6A15B6F-E302-4E05-9B3B-FA07A3A54E61Q27002459-8BD59861-5E9F-445C-8E51-5D27D8F2A3AFQ28080057-5164076C-5ADB-4E6C-8681-3DECE62A637CQ28080067-A6742580-FFA3-4758-BBEC-C21C159380A0Q28574407-A877EBD8-2B17-4622-A9D2-FDF0B89850C3Q30301118-77D1ECD4-528E-4D42-ABBF-9C7E0028BB2DQ30362092-540489EF-1933-40EC-ACE9-E96377818632Q30408455-AD1BAB47-574A-4662-9B41-1556E5FBAE64Q33672280-9E63615A-4771-476B-BD98-193A9266DDC4Q33736504-1E6D3C02-F918-4982-A6D6-755753CD67DAQ33796018-3ED323D5-D92E-49AB-86D6-65A4191C50C5Q33809886-2911E265-2C24-4F58-9576-D18081CB8615Q33935375-4DF0EC52-80AF-4CE4-A9CF-183638F00D59Q33987863-7A805A6B-A273-4CA6-86F0-4BCA207B7103Q34038623-DEB1991C-B6AE-49B4-A665-3153DE45F406Q34152435-7F219B55-72F9-4F1D-9617-CC182DC178D6Q34245190-083D85C6-D6D1-4ABD-9BFA-69EBAC867C6EQ34459287-F535C58E-9FE2-4F2F-9038-2F2C094D4C18Q34501103-0F11BF1B-CBBF-48BB-A7F9-9F25B34D1325Q34512181-80F31BCE-A4CC-43CE-974C-4888FEB45D69Q34586543-20F21AA1-235A-4EA8-8735-84CCB4E338C6Q34628776-D44A0BBF-9335-4B71-B6DF-0035873A4947Q35165909-F996A35A-7E04-4C81-8D33-2C9146928268Q35167928-42267B32-0667-498C-AD1D-89AEE0AC1FF7Q35194360-1F687128-53B8-4291-A9D1-3BA609DE6F8BQ35286858-09F5705E-96B4-4BD4-9CEA-6D39DF724683Q35581462-7178CD66-CD8C-4688-A7A5-6A0B399203A5Q35623691-0B26E307-E196-4A84-907C-4898A23BC64FQ35651787-5D594A0D-58A9-4B01-86C8-EE6386DD4189Q35780290-8C22EF16-789C-46F4-8DEF-D9A37E96A292Q35810679-38F11479-FC04-4A25-BDD7-D5329CEB5DB1Q35977390-E09181FD-528A-4414-80E2-5BAE11C7CF72Q36176127-B4DFFAB8-4C43-4ADF-9B4E-73F77222176FQ36492259-7C895338-4BA3-4B2B-8F18-2E6DD3970A11Q36738639-0A062C76-245C-49E1-97E4-5498125D5716Q36783718-558D1F3E-3CD8-4C21-9448-0A69AEE9A25AQ36814743-FB464B6B-2BBF-4423-BEFB-D01A4A50B8B7Q36828657-96E018F1-C48A-435C-83EC-7D2C202D5E2CQ36930808-B269C752-5D63-4882-BDA2-A01776BBEDF0
P2860
Diabetic cardiomyopathy: mechanisms, diagnosis and treatment.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Diabetic cardiomyopathy: mechanisms, diagnosis and treatment.
@ast
Diabetic cardiomyopathy: mechanisms, diagnosis and treatment.
@en
type
label
Diabetic cardiomyopathy: mechanisms, diagnosis and treatment.
@ast
Diabetic cardiomyopathy: mechanisms, diagnosis and treatment.
@en
prefLabel
Diabetic cardiomyopathy: mechanisms, diagnosis and treatment.
@ast
Diabetic cardiomyopathy: mechanisms, diagnosis and treatment.
@en
P356
P1433
P1476
Diabetic cardiomyopathy: mechanisms, diagnosis and treatment
@en
P2093
Billal Patel
Rajdeep S Khattar
P304
P356
10.1042/CS20040057
P407
P577
2004-12-01T00:00:00Z